Endoscopic hemostasis using covered metallic stent placement for uncontrolled post-endoscopic sphincterotomy bleeding

Endoscopy. 2011 Apr;43(4):369-72. doi: 10.1055/s-0030-1256126. Epub 2011 Feb 28.

Abstract

Severe bleeding following endoscopic biliary sphincterotomy (EBS) can sometimes be difficult to manage, resulting in the need for an invasive intervention. The aim of this study was to retrospectively evaluate the feasibility and efficacy of endoscopic hemostasis using covered self-expandable metallic stents (SEMSs) for severe post- EBS bleeding. Eleven patients with bile duct stones underwent standard EBS using a standard sphincterotome-based technique at 4 endoscopic units of a university-affiliated hospital and a general hospital. Monotherapy or combined therapy were used to achieve hemostasis with either balloon tamponade, hypertonic saline epinephrine injection, or endoclip placement. When active bleeding could not be controlled, covered SEMSs were placed across the major papilla. Emergency endoscopy was performed on the day of admission or the subsequent day (ranging from 6 to 35 h after admission). Bleeding was classified as mild in 6 cases (54.5 %) and moderate in 5 (45.5 %). A covered SEMS 10mm in diameter and 6 cm long was placed across the papilla. After placement, complete hemostasis was achieved. The mean duration of stent placement was 8.2 days (range 5–10 days), and the SEMS was successfully removed in all cases. Although the present study has the limitations of a small sample size and lack of control patients, covered SEMS placement for endoscopic hemostasis may be useful in selected patients with uncontrolled post-EBS bleeding.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Coated Materials, Biocompatible
  • Emergencies
  • Female
  • Hemorrhage / diagnosis
  • Hemorrhage / etiology
  • Hemorrhage / therapy*
  • Hemostasis, Endoscopic*
  • Humans
  • Male
  • Middle Aged
  • Sphincterotomy, Endoscopic / adverse effects*
  • Stents*

Substances

  • Coated Materials, Biocompatible